alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
SERVED : JUN E1,201 1 U.S . DEPARTMEN T O FTRANSPORTATIO N

OFFIC EO FHEARING S WASHINGTON , D C 

### ..^RMvJENTO F

A S : 3 U INTH EMATTERO F COMLU X AVIATIO N SERVICE S LL C FA A DOCKE T NO . [T O B EASSIGNED ]

(Civi l Penalty Action ) FDM S NO . FAA-2011-029 1 NOTIC EO FASSIGNMEN T AN D DISMISSA LO FPROCEEDIN G Thi s proceedin g (heretofore designateda s Cas e No . EI R2010-GL-11-0109 ) wa s receive d inth e Offic e o f

Hearing s o n Apri l 21 , 2011 , an dha s bee nassigne dt o th e undersigned . O n May 12 , 2011 , Responden t move dt o withdre w it s reques t for hearing , statin g that

th e partie s hav e settle dth e matter; ' an dComplainan t withdre w it s complaint , askin g tha t th e cas e b e dismissed. ^ Accordingly , pursuan t t o 1 4 C.F.R . § 13.215 , Respondent' s motio ni s grante dan d thi s proceedin g i s dismisse dwithprejudice . Th e FA A shal l sen dth e Judg e an dth e Docke t acop y o f

an y compromis e orde r

o r final order assessin g civi l penalty . S O ORDERED .

Ronnie A . Yod e Chie f Administrativ e Attachmen t

- Servic e Lis t

' Respondent' s Motion to Withdra w the Request

fo r Hearing , a

t 1 . ^ Withdrawa

l of Complaint , a

t 1 .

### i M FDM S NO . FAA-201 1 -029 1 | (Civi l Penalty Action ) | 

# I SERVIC ELIS T | li s 

### i ORIGINA L& ON ECOP Y li i} ;

^.• ^ Federal Aviatio n Administratio n f , 80 0 Independenc e Avenue , S.W . | | S, ! Washington , D C 2059 1 Attention : Hearin g Docke t Clerk , AGC-43 0 | i Wilbu r Wrigh t Building—Suit e 2Wl000 ^ |

ON ECOP Y i l Jaso n Dickstein , Respondent' s Counse l | | Washingto nAviatio n Group , P C an dth e f ^ La w Office s o f

Jaso n A . Dickstei n | ! 223 3 Wisconsi n Avenue , N.W. , Suit e 50 3 ^ | Washington , D C 2000 7 0 1 TEL : 202-628-677 6 f 1 FAX : 202-628-894 8 | | Chri s G . Zurales , Complainant' s Counse l I Offic e o f th e Regiona l Counsel , AGL-7 K ; 3 Great Lake s Regio n | Federal Aviatio n Administratio n 230 0 Eas t Devo n Avenu e DesPlaines,I L60018-469 6 j | TEL : 847-294-771 3 '" : FAX : 847-294-749 8 - Th e Honorabl e Ronni e A . Yoder , Chie f Administrativ e Law Judg e U.S . Departmen t

o f Transportatio n Offic e o f Hearings , M-20 , Roo mE l 2-32 0 i 120 0 Ne w Jerse y Avenue , S.E . Washington , D C 2059 0 TEL : 202-366-214 2 FAX : 202-366-753 6

^ Servic e wa s b y U.S . Mail . Fo

r servic e i n perso n o r b y expedite dcourier , us e th e followin g address : Federa

l Aviatio n Administration

, 60 0 Independenc

e Avenue, S.W. , Wflb

w Wrigh t Building—Suit

e 2W1000, Washington

, D C 20591 ; Attention : Hearin

g Docke t Clerk , AGC-430 . - 2 -
Appendix P

Article Summary Information for 

Study Topics 

	Article Summary Information for Study Topics

	Topic		# of

	Studies		# of Eyes 	Enrolled

	Range

	(mean/median)		Mean Age

	Range

	(mean/median)		Proportion of 	Patients

	African-American

	Range

	(mean/median)		Mean Reported Followup

	Range

	(median)		Quality Score

	Mean

	(Range)

Long-Term IOP Control	44	19 to 310

(110/88)	63 to 81

(74/74)	0.0 to 0.17

(0.06/0.03)	6-11 months to ≥24 months

(12-23 months)	50%a

(2% to 83%)

Short-Term IOP Control	15	16 to 310

(96/68)	69 to 80

(74/75)	0.07 to 0.31

(0.14/0.11)	≤24 hours to 12-23 months

(6-11 months)	55%b

(23% to 75%)

Development of Cataract after Glaucoma Surgery	22	22 to 776

(175/140)	50 to 72

(62/63)	0.05 to 1.0

(0.29/0.12)	3-5 months to ≥24 months

(12-23 months)	64%c

(23% to 88%)

Risks/Benefits of Anti-Fibrosis Agents	16	24 to 174

(62/44)	50 to 76

(71/74)	0.03 to 0.77

(0.36/0.03)	3-5 months to ≥24 months

(12-23 months)	61%d

(33% to 80%)

One-Site versus Two-Site Procedures	7	20 to 132

(68/50)	65 to 78

(74/75)	Reported for only one study.	6-11 months to 12-23 months

(12-23 months)	40%e

(10% to 64%)

Nuclear Expression versus Phacoemulsification	11	47 to 397

(117/70)	71 to 78

(76/76)	0 to 0.11

(0.04/0)	6-11 months to ≥24 months

(12-23 months)	40%f

(13% to 54%)

Staged versus Combined Procedures	5	40 to 106

(76/79)	50 to 76

(67/71)	0.08 to 0.24

(0.16/0.16)	12-23 months to ≥24 months

(12-23 months)	Calculated only for one study.

Trabeculectomy versus Other Glaucoma Procedures	3	58 to 70

(63/60)	78 to 80

(79/79)	Reported for only one study.	Reported for only one study.	43%g

(21% to 59%)

_________________________

		a 30  studies

		b 15 studies

		c 13 studies

		d 14 studies

		e 7 studies

		f 11 studies

		g 3 studies
[No. 3232.]

#### Martin Shubert *v.*The State.

1. Obstruction op Public Road—Evidence.—Even in cases where the obstruction is placed upon the road proper, the evidence must show that the obstruction was wilful. *A*fortiori, when the obstruction is consequential—arises from an act which the accused had the legal right to do— the evidence must show that the act was wilfully done, and with a view , o such indirect or consequential effects. See the opinion for a case in illustration.

3. Interpretation op a Term.—When used in a penal statute, the term “wilful” means with evil intent, or legal malice, or without reasonable 1 ground for believing the act to be lawful.

Appeal from the County Court of Hays. Tried below before the Hon. E. R. Kone, County Judge.

The opinion discloses the nature of the case. The punishment imposed was a fine of twenty-five dollars.

*Hutchison & Franklin,*for the appellant.

*J. H. Burts,*Assistant Attorney General, for the State.

White, Presiding Judge.

The road alleged to have been obstructed was a public road, crossing the Blanco river at a ford on defendant’s land. Some distance, several hundred yards, below the ford, defendant erected a dam across said river on his own land, for the purpose of operating machinery to irrigate his garden. By the erection of this dam the water was raised or backed up at the ford so as to somewhat interfere with and impede the travel across the river.

It will be noted that the obstruction complained of is not one placed directly in or across the road. It was one entirely consequential upon another act of defendant, which in itself was legal, and in its purposes legitimate, in the use of his own property. Our statute in all cases makes the criminality of this particular offense of obstructing or injuring a public road to depend upon the fact that the act constituting the offense was “wilfully” done. (Penal Code, Art. 405; *Brinkoeter*v. *The State,*14 Texas Ct. App., 67.)

*646If necessary that the act should be shown to have been “wilfully” committed, even in cases of direct obstruction—as where the obstruction is placed by the defendant directly across or in the *road—a fortiori*where the obstruction is consequential or indirect, and is occasioned by an act in itself legal, the State should establish beyond all question that the act was *wilfully*done, and with a view to such indirect or consequential effects. *(Prine*v. *The State,*36 Ala., 244.)

The word “wilfully” is the word used in the statute to characterize the offense. “When used in a penal statute, the wore * wilful’ means more than it does in common parlance. It mear if with *evil intent*or legal malice, or without reasonable ground for believing the act to be lawful.” *(Thomas*v. *The State,*13 Texas Ct. App., 200.)

The evidence fails to show that the acts complained of, and upon which this conviction is based, were “wilfully” done. The judgment is reversed and the cause remanded.

*Reversed and remanded*

Opinion delivered June 27, 1884.
```

[Federal Register Volume 77, Number 96 (Thursday, May 17, 2012)]
[Notices]
[Pages 29344-29345]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-11953]

=======================================================================
-----------------------------------------------------------------------

EXPORT-IMPORT BANK OF THE UNITED STATES

Economic Impact Policy

    This notice is to inform the public that the Export-Import Bank of 
the United States has received an application for a $4.3 billion direct 
loan to support the export of approximately $3.3 billion in U.S. 
equipment and services to establish a new petrochemical facility in 
Saudi Arabia.
    The U.S. exports will enable the facility to produce approximately: 
750,000 metric tons of linear low density polyethylene (LLDPE); 350,000 
metric tons of linear density polyethylene (LDPE); 250,000 metric tons 
of elastomers; 200,000 metric tons of glycol ethers; 70,000 metric tons 
of propylene glycol (MPG); 208,000 metric tons of ethanolamines and 
ethyleneamines; 400,000 metric tons of polyether polyols; 200,000 
metric tons of toluene diisocyanate (TDI); and 400,000 metric tons of 
polymeric methyl diphenyl diisocyanate (PMDI). Initial production at 
this facility is expected to be phased in from 2016 to 2018.
    Available information indicates the Saudi petrochemical producer 
plans to sell its products as follows: The majority of LDPE, LLDPE and 
glycol ethers will be sold primarily in the Asia-Pacific market, and 
the balance will be sold in the Europe, Middle East and Africa

[[Page 29345]]

markets; the majority of elastomers, TDI, PMDI, and polyether polyols 
will be sold primarily in Asia-Pacific, Europe, Middle East and Africa 
markets and minority will be sold in the North and Latin America; 
approximately equal volumes of MPG will be sold primarily in Asia-
Pacific, Europe, Middle East and Africa markets; and approximately 
equal volumes of ethanolamines and ethyleneamines will be sold 
globally.
    Interested parties may submit comments on this transaction by email 
to economic.impact@exim.gov or by mail to 811 Vermont Avenue NW., Room 
947, Washington, DC 20571, within 14 days of the date this notice 
appears in the Federal Register.

Angela Mariana Freyre,
Senior Vice President and General Counsel.
[FR Doc. 2012-11953 Filed 5-16-12; 8:45 am]
BILLING CODE 6690-01-P
```
No. 11-10056.

#### Morillo-Hidalgo v. United States.

C. A. 2d Cir. Certiorari denied.
STATEOFWASHINGTONDEPARTMENTOFECOLOGYPO11ox47600•Olympia,WA98504-7600•360-407-6000711 forWashingtonUelayService•Personswithaspeecl1disabilitycc1ncall877-833·6341July31,2013TO:JimPendowski,ManagerToxicsCleanupProgramFROM:MaiaD.Bellon,DirectorSUBJECT:DeterminationofApplicationofMTCAPermitExemption,RCW70.105D.090,toAirQualityProgramPermitsUnderRCW70.105D.090(2),ModelToxicsControlAct(MTCA)exemptspattiesconductingcleanupsunderorderordecreefromhavingtoobtaincertainpermits.However,thepermitexemption"shallnotapplyif[Ecology]determinesthat theexemptionwouldresultinlossofapprovalfromafederalagencynecessaryforthestatetoadministeranyfederallaw,including...thefederalcleanairact[.]"TheDepartmentofEcology(Ecologyorwe)hasdetermined thatwecannolongerusetheMTCAexemptiontoexemptfrompermittingairemissionsfromremedialactionsatMTCAclean-upsitesthataresufficienttotriggertheneedforTitleVairoperatingpermits(AOPs),preventionofsignificantdeteriorationpermits(PSDpermits),ornonattainmentnewsourcereviewpermits(nonattainmentNSRpermits).ThesepermitsaremandatedbytheFederalCleanAirAct(CAA).See42U.S.C.§7475(requiringPSDpermits);42U.S.C.§766la(requiringTitleVairoperatingpermits);42U.S.C.§7502(c)(5)(requiringNonattainmentNSRpermits).PursuanttotheCAA,theUnitedStatesEnvironmentalProtectionAgency(EPA)hasauthorizedEcologytoissuethesepermits.OnlyCongresscancreateexemptionstotheCAA'srequirementthatthesepermitsbeissuedwhenairemissionsaresufficienttotriggertheneedforthem.Basedonthisanalysis,wearedetermining,pursuanttoRCW70.105D.090(2),thattheapplicationofthepermitexemptionRCW70.I05D.090(1)toairemissionsfromremedialactionsatMTCAcleanupsitesthatwouldotherwiserequirePSDpermits,TitleVAOPs,orNonattairunentNSRpermitswouldresultinthestate'slossoffederalauthorizationtoimplementtheseCAApermittingrequirementsinWashington.ThisdeterminationappliessolelytoemissionsintotheairfromremedialactionsatMTCAcleanupsites,andisnotintendedtoapplytoanyothercircumstance.Inaddition,thefederalCleanAirActrequiresWashingtontodevelopandimplementaplan(SIP)fortheattaimnentandmaintenanceofthenationalambientairqualitystandards(NAAQS).Washington'sSIPincludestherequirementthateachnewormodifiedminorsourceofairpollutantsinWashingtonfileanoticeofconstructionwithEcology,andobtainapermitregulatingitsairemissions.Washington'sSIPhasbeenapprovedbyEPAand,asaresult,hasbecomeenforceablefederalla\v.Ecology'sfailuretoimplementthepermitrequirementsintheSIPcouldresultinsanctionsagainstthestateandtheissuanceofafederalplan(FIP).Basedonthisanalysis,wearedetermining,pursuanttoRCW70.105D.090(2),thatuntiltheMTCAexemptionforminorsourcepermitsareapprovedintoWashington'sSIP,applicationofthepermitexemptionRCW70.105D.090(1)toremedialactionsatMTCAcleanupsitesthatemitNAAQSpollutantsortheirprecursorswouldresultinthestate'slossoffederalauthorizationtoimplementtheseCAApermittingrequirementsinWashington.ThisdeterminationappliessolelytoNAAQSpollutantswhichwouldbeemittedintotheairfromremedialactionsatMTCAcleanupsites,andisnotintendedtoapplytoanyothercircumstance.cc:ToxicsCleanupProgramManagementTeamAirQualityProgramManagementTeamKayShirey,AssistantAttorneyGeneralIvyAnderson,AssistantAttorneyGeneral
<PAGE>

Exhibit 31.1.     Section 302 Certification of CEO

I, Alan Lindsay, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of MIV Therapeutics,
Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

(a) Designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared; (b) Evaluated the
effectiveness of the registrant's disclosure controls and procedures as of a
date within 90 days prior to the filing date of this quarterly report (the
"Evaluation date"); and (c) Presented in this quarterly report our conclusions
about the effectiveness of the disclosure controls and procedures based on our
evaluation as of the Evaluation date;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the registrant's board
of directors:

(a) All significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls, and (b) Any fraud,
whether or not material, that involves management or other employees who have a
significant role in the registrant's internal controls; and

6. The registrant's other certifying officers and I have indicated in this
quarterly report whether there were significant changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date : January 14, 2007


/s/ Alan Lindsay
-----------------------
Alan Lindsay
CEO and Chairman
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Interior

###### Bureau of Land Management

          - [OR-4310-33]

# AGENCY:

Bureau of Land Management, Interior.

# ACTION:

Notice of renewal of the Steens Mountain Advisory Council.

# SUMMARY:

This notice is published in accordance with Section 9(a)(2) of the Federal Advisory Committee Act of 1972, Public Law 92-463. Notice is hereby given that the Secretary of the Interior (Secretary) has renewed the Bureau of Land Management's Steens Mountain Advisory Council.

The purpose of the Council will be to advise the Secretary with respect to the preparation and implementation of the Steens Mountain Cooperative Management and Protection Area Management Plan.

# FOR FURTHER INFORMATION CONTACT:

Maggie Langlas, National Landscape Conservation System (171), Bureau of Land Management, 1620 L Street, NW., Room 301 LS, Washington DC 20236, telephone (202) 452-7787.

## Certification Statement

I hereby certify that the renewal of the Steens Mountain Advisory Council is necessary and in the public interest in connection with the Secretary's responsibilities to manage the lands, resources, and facilities administered by the Bureau of Land Management.

Dated: August 4, 2006.

Dirk Kempthorne,

Secretary of the Interior.

[FR Doc. 06-6866 Filed 8-10-06; 8:45 am]

BILLING CODE 4310-DQ-M
Exhibit 10.2 Product Brochure in Japan


 


BENE IO


 


Our first objective is to provide a healthy daily life style.


 


Easy to take soft capsules


 


The soft football-shaped capsules are easy to take.


 


The letters, “BENE” are printed on each capsule verifying its originality.


 


PINE BENE IO


 


Aluminum Pack (90 pcs)


 


Suggested Retail Price 11,550 Yen


 


PINE BENE IO


 


Compact Case (30 pcs)


Suggested retail 4,200 yen


 


Name of Product


Pine Bene IO (An Extract from Pine Bark)


 


Type of Product 


Health Supplement


 


 









NAME OF INGREDIENTS


 


DHA (Docosahexaenoic Acid) – Refined fish oil


 


Safflower Oil


 


Blueberry Extract


 


Coenzyme Q10


 


Pine Bark Extract


 


Gelatin


 


Soy Lecithin


 


Glycerine


 


Vitamin E


 


Glycerine Fatty Acid Ester


 


Marigold Pigment


 


Vitamin C


 


Page 2 of brochure


 


RETAIL COST


 


Suggested retail cost


 





	
             
 	
            (a)
 	
            90 pcs, approx. 47.7 grams – 11,550 yen (including tax)
 









	
             
 	
            (b)
 	
            30 pcs, approx. 15.9 – 4,200 yen (including tax)
 






 


Repeat Order Pricing





	
             
 	
            (a)
 	
            90 pcs, approx. 47.7 grams – 9,450 yen (tax included)
 






 









DIRECTIONS FOR USAGE


 


For use as a supplement, the recommended dosage is three (3) capsules every day with water (warm or cold).  Swallow the capsules whole without chewing as the ingredients have a purplish color.


 


Warning:  If for any reason there is any reaction, please consult a physician.


 


RIGHT SIDE COLUMN


 


NUTRITIONAL FACTS


 


3 CAPSULES


 





	
            Calorie
 	
            9.9 kcal
 





 





	
            Protein
 	
            0.4 g
 





 





	
            Lipids
 	
            0.8 g
 





 





	
            Carbohydrates
 	
            0.3 g
 





 





	
            Sodium
 	
            0.4 mg
 





 





	
            Vitamin A (Retinal)
 	
            12.2 ug
 





 





	
            Vitamin E
 	
            46.6 mg
 





 





	
            Vitamin C
 	
            9.2 mg
 





 


(Analytic Examination by the Japan Food Analysis Center)


 


INGREDIENTS AND CONTENT


 


With 3 capsules


 





	
            Lutein
 	
            6.36 mg
 





 





	
            Zeaxanthin
 	
            0.27 mg
 





 








 





	
            Phospatidyl Choline
 	
            82.11 mg
 





 





	
            Docosahexaenoic Acid
 	
            100.05 mg
 





 





	
            Anthocyanin
 	
            28.35 mg
 





 





	
            Coenzyme Q10
 	
            30 mg
 





 


(Analytic Examination by the Japan Food Analysis Center)


 





	
            Seller:
 	
            Bene IO (Japan Office)
 





2-9-1 Akabane, Kita-ku, Tokyo  


 


(*Translator’s note: this is the company’s new Japan address; the old address is the one actually on the brochure.)


 


For manufacturing information: Korin Pharmaceutical


Toll Free: 0120-520-310
No. 11-5736.

#### Waters *v.*United States.

Ct. App. D. C. Certiorari denied.
Editorial Note on Part 74
Editorial Note: Nomenclature changes to part 74 appear at 64 FR 4055, Jan. 27, 1999.

§ 74.751 Modification of transmission systems. ( a ) No change, either mechanical or electrical, may be made in apparatus which has been certificated by the Commission without prior authority of the Commission. If such prior authority has been given to the manufacturer of certificated equipment, the manufacturer may issue instructions for such changes citing its authority. In such cases, individual licensees are not required to secure prior Commission approval but shall notify the Commission when such changes are completed.
( b ) Formal application (FCC Form 2100, Schedule C) is required for any of the following changes: ( 1 ) Replacement of the transmitter as a whole, except replacement with a transmitter of identical power rating which has been certificated by the FCC for use by low power TV and TV translator stations, or any change which could result in a change in the electrical characteristics or performance of the station.
( 2 ) Any change in the transmitting antenna system, including the direction of radiation, directive antenna pattern, antenna gain, transmission line loss characteristics, or height of antenna center of radiation.
( 3 ) Any change in the overall height of the antenna structure, except where notice to the Federal Aviation Administration is specifically not required under § 17.14(b) of this chapter.
( 4 ) Any horizontal change of the location of the antenna.
( 5 ) A change in frequency assignment.
( 6 ) [Reserved]
( 7 ) A change of authorized operating power.
( c ) Notwithstanding the requirements in paragraph (b) of this section, a station may file in LMS a correction of geographic coordinates where the change is 3 seconds or fewer in latitude and/or 3 seconds or fewer in longitude, provided there is no physical change in location and no other licensed parameters are changed. An exhibit should be attached to the application(s) specifying that it is a coordinate correction.
( d ) Upon installation of new or replacement transmitting equipment for which prior FCC authority is not required under the provisions of this section, the licensee must place in the station records a certification that the new installation complies in all respects with the technical requirements of this part and the station authorization.
[28 FR 13722, Dec. 14, 1963, as amended at 38 FR 6827, Mar. 13, 1973; 39 FR 38652, Nov. 1, 1974; 45 FR 26067, Apr. 17, 1980; 47 FR 21501, May 18, 1982; 48 FR 41423, Sept. 15, 1983; 50 FR 23710, June 5, 1985; 52 FR 31405, Aug. 20, 1987; 63 FR 33879, June 22, 1998; 63 FR 36605, July 7, 1998; 67 FR 13233, Mar. 21, 2002; 87 FR 58203, Sept. 23, 2022; 88 FR 30669, May 12, 2023]
No. 11-9653.

#### Raghunathan et ux. *v.*Chase Home Finance, LLC.

Super. Ct. Pa. Certiorari denied.